Structural variations in copper(I) iodide coordination polymers of sulfide and disulfide containing flexible 3-substituted pyridine ligands

The three-substituted dipyridyl ligand bis(3-pyridylmethyl)sulfide (L¹) was prepared by the reaction of 3-(chloromethyl)pyridine hydrochloride with thioacetamide under basic conditions. L¹ was reacted with CuI to give complexes with 1:2 and 1:1 molar ratios. Crystal structures of [(CuI)₂(L¹)]_∞ (1) and [CuI(L¹)]_∞ (2) were determined. In complex 1 the CuI species formed a one-dimensional staircase polymer to which L¹ was bound in a side-by-side fashion with π-π interactions between the ligands on each side. Complex 2 consisted of a one-dimensional ribbon polymer of metallomacrocycles formed from two L¹ ligands bridging Cu₂I₂ dimers which were fused within the macrocyclic ring. The analogous disulfide ligand bis(3-pyridylmethyl)disulfide (L²) was prepared by oxidation of the corresponding thiol 3-(sulfanylmethyl)pyridine. L² was reacted with CuI in 1:2 and 1:1 molar ratios and products isolated but only the 1:1 product was able to be crystallised. The crystal structure of [CuI(L²)]_∞ (3) consisted of a one-dimensional ribbon polymer of metallomacrocycles formed from two L² ligands linked through Cu₂I₂ dimers. The difference in the metallomacrocycle linking between the related structures 2 and 3 was attributed to the difference in ligand conformation.     

Mn(II) coordination architectures with mixed ligands of 3-(2-pyridyl)pyrazole and carboxylic acids bearing different secondary coordination donors and pendant skeletons

In our efforts to investigate the factors that affect the formation of coordination architectures, such as secondary coordination donors and pendant skeletons of the carboxylic acid ligands, as well as H-bonding and other weak interactions, two kinds of ligands: (a) 3-(2-pyridyl)pyrazole (L¹) with a non-coordinated N atom as a H-bonding donor, a 2,2′-bipyridyl-like chelating ligand, and (b) four carboxylic ligands with different secondary coordination donors and/or pendant skeletons, 1,4-benzenedicarboxylic acid (H₂L²), 4-sulfobenzoic acid (H₂L³), quinoline-4-carboxylic acid (HL⁴) and fumaric acid (H₂L⁵), have been selected to react with Mn(II) salts, and five new complexes, [Mn(L¹)₂(SO₄)]₂ (1), [Mn(L¹)₂(L²)]_∞ (2), [Mn(L¹)(HL³)₂]_∞ (3), Mn(L¹)₂(L⁴)₂ (4), and [Mn(L¹)₂(L⁵)]_∞ (5), have been obtained and structurally characterized. The structural differences of 1-5 can be attributed to the introduction of the different carboxylic acid ligands (H₂L², H₂L³, HL⁴, and H₂L⁵) with different secondary coordination donors and pendant skeletons, respectively. This result also reveals that the typical H-bonding (i.e. N-H?O and O-H?O) and some other intra- or inter-molecular weak interactions, such as C-H?O weak H-bonding and π?π interactions, often play important roles in the formation of supramolecular aggregates, especially in the aspect of linking the multi-nuclear discrete subunits or low-dimensional entities into high-dimensional supramolecular networks.     

Characterization of aspartate kinase and homoserine dehydrogenase from <Emphasis Type="Italic">Corynebacterium glutamicum</Emphasis> IWJ001 and systematic investigation of <Emphasis Type="SmallCaps">l</Emphasis>-isoleucine biosynthesis

Previously we have characterized a threonine dehydratase mutant TD^F383V (encoded by ilvA1) and an acetohydroxy acid synthase mutant AHAS^{P176S, D426E, L575W} (encoded by ilvBN1) in Corynebacterium glutamicum IWJ001, one of the best l-isoleucine producing strains. Here, we further characterized an aspartate kinase mutant AK^A279T (encoded by lysC1) and a homoserine dehydrogenase mutant HD^G378S (encoded by hom1) in IWJ001, and analyzed the consequences of all these mutant enzymes on amino acids production in the wild type background. In vitro enzyme tests confirmed that AK^A279T is completely resistant to feed-back inhibition by l-threonine and l-lysine, and that HD^G378S is partially resistant to l-threonine with the half maximal inhibitory concentration between 12 and 14 mM. In C. glutamicum ATCC13869, expressing lysC1 alone led to exclusive l-lysine accumulation, co-expressing hom1 and thrB1 with lysC1 shifted partial carbon flux from l-lysine (decreased by 50.1 %) to l-threonine (4.85 g/L) with minor l-isoleucine and no l-homoserine accumulation, further co-expressing ilvA1 completely depleted l-threonine and strongly shifted carbon flux from l-lysine (decreased by 83.0 %) to l-isoleucine (3.53 g/L). The results demonstrated the strongly feed-back resistant TD^F383V might be the main driving force for l-isoleucine over-synthesis in this case, and the partially feed-back resistant HD^G378S might prevent the accumulation of toxic intermediates. Information exploited from such mutation-bred production strain would be useful for metabolic engineering.     

Conversion of glycerol to 1,3-dihydroxyacetone by glycerol dehydrogenase co-expressed with an NADH oxidase for cofactor regeneration

Objectives

To investigate the efficiency of a cofactor regeneration enzyme co-expressed with a glycerol dehydrogenase for the production of 1,3-dihydroxyacetone (DHA).

Results

In vitro biotransformation of glycerol was achieved with the cell-free extracts containing recombinant GlyDH (glycerol dehydrogenase from Escherichia coli), LDH (lactate dehydrogenase form Bacillus subtilis) or LpNox1 (NADH oxidase from Lactobacillus pentosus), giving DHA at 1.3 g l^?1 (GlyDH/LDH) and 2.2 g l^?1 (GlyDH/LpNox1) with total turnover number (TTN) of NAD⁺ recycling of 6039 and 11100, respectively. Whole cells of E. coli (GlyDH–LpNox1) co-expressing both GlyDH and LpNox1 were constructed and converted 10 g glycerol l^?1 to DHA at 0.2–0.5 g l^?1 in the presence of zero to 2 mM exogenous NAD⁺. The cell free extract of E. coli (GlyDH–LpNox) converted glycerol (2–50 g l^?1) to DHA from 0.5 to 4.0 g l^?1 (8–25 % conversion) without exogenous NAD⁺.

Conclusions

The disadvantage of the expensive consumption of NAD⁺ for the production of DHA has been overcome.

     

Allelic differentiation at the <Emphasis Type="Italic">Sg-1</Emphasis> locus for the terminal sugar of the C-22 position of group A saponin in Chinese wild soybean (<Emphasis Type="Italic">Glycine soja</Emphasis> Sieb. &amp; Zucc.)

Group A saponins are thought to be the cause of bitter and astringent tastes in processed foods of soybean (Glycine max), and the elimination of group A saponins is an important breeding objective. The group A saponins include two main Aa and Ab types, controlled by codominant alleles at the Sg-1 locus that is one of several key loci responsible for saponin biosynthesis in the subgenus Glycine soja. However, A0 mutant lacking group A saponin is a useful gene resource for soybean quality breeding. Here, eight Chinese wild soybean A0 accessions were sequenced to reveal the mutational mechanisms, and the results showed that these mutants were caused by at least three kinds of mechanisms involving four allelic variants (sg-1^0-b2, sg-1^0-b3, Sg-1^b-0, and Sg-1^b-01). The sg-1^0-b2 had two nucleotide deletions at positions +?72 and +?73 involving in the 24th and 25th amino acids. The sg-1^0-b3 contained a stop codon (TGA) at the 254th residue. The Sg-1^b-0 and Sg-1^b-01 were two novel A0-type mutants, which likely carried normal structural alleles, and nevertheless did not encode group A saponin due to unknown mutations beyond the normal coding regions. In addition, to reveal the structural features, allelic polymorphism, and mechanisms of the abiogenetic absence of group A (i.e., A0 phenotype), nucleotide sequence analysis was performed for the Sg-1 locus in wild soybean (Glycine soja). The results showed that Sg-1 alleles had a lower conservatism in the coding region; as high as 18 sequences were found in Chinese wild soybeans in addition to the Sg-1^a (Aa) and Sg-1^b (Ab) alleles. Sg-1^a and Sg-1^b alleles were characterized by eight synonymous codons and nine amino acid substitutions. Two evolutionarily transitional allelic sequences (Sg-1^a7 and Sg-1^b2) from Sg-1^a toward Sg-1^b were detected.     

Versuch einer quantitativen Beschreibung des Formensehens der Honigbiene

1. Form discrimination by honeybees can be measured when individuals are trained to select a rewarded shape in preference to other, unrewarded ones (Table 2). In these experiments, the values of discrimination for some pairs of shapes depend upon which of the pair is rewarded (“symmetrical, asymmetrical discrimination”, Table 3, 4).
2. Two groups of possible mechanisms of form discrimination will be discussed. Experimental findings preclude the exclusive use by the bees of any one of those mechanisms. The following discrimination function, however, describes the present as well as previously reported results: $$U = \left| {C_{\text{1}} \frac{{R^ + + R^ - }}{G}F^ + + C_2 {\text{(log}}K^ + {\text{ - log}}K^ - {\text{)}}} \right|$$ (Figs. 4, 5, 7, 8, 9, 10). R ⁺, R ^?, G and F ⁺ are parts of areas (Fig. 1), K ⁺ and K ^? contour lengths of the shapes to be compared.
3. The weighting factors, C ₁ and C ₂, are apparently given different values by the bee for different shape combinations. Some results might support Mazochin-Porshnyakov's (1969) hypothesis that bees can also recognize other features of the shapes, according to the problem to be solved (Sect. D).

     

Coordination chemistry of heterocycle-functionalized diazamesocycles: tuning the productive Ni complexes through altering the pendants of ligands

In order to further understand the coordination chemistry of diazamesocyclic systems, a series of mononuclear Ni^II complexes with 1,4-diazacycloheptane (DACH) functionalized by additional imidazole or pyridine donor pendants, including [NiL¹](ClO₄)₂ · H₂O (1), [NiL¹Cl](ClO₄) (2), [NiL²Cl](ClO₄) · CH₃OH (3), [NiL²Cl][NiL²](ClO₄)₃ (4) and [NiL³](ClO₄)₂ (5), where L¹ = 1,4-bis(N-1-methylimidazol-2-yl-methyl)-1,4-diazacycloheptane, L² = 1,4-bis(pyridyl-2-yl-methyl)-1,4-diazacycloheptane, and L³ = 1,4-bis-(imidazol-4-yl-methyl)-1,4-diazacycloheptane, have been prepared and characterized. A detailed study on the solid structures and solution spectra of these complexes indicates that tetradentate ligands L¹, L² and L³ would lead to new Ni^II complexes with different coordination environments in the solid states and solution. The N-methyl substituted imidazole functionalized ligand L¹ forms green compound 2 and yellow product 1; while the pyridine functionalized ligand L² affords red product 4 and green complex 3; the ligand L³ results in only one stable mononuclear Ni^II product 5. The solution behaviors of these interesting compounds were also investigated by UV-Vis technique.     

The effect of genetic environment on locus-specific instability of the <Emphasis Type="Italic">yellow</Emphasis> gene in the Uman’ population of <Emphasis Type="Italic">Drosophila melanogaster</Emphasis>

The effects of genotype of the laboratory strains, C(1)DX, ywf/Y, 23.5 MRF/CyL ⁴, and C(1)DX,yf; π₂, on locus-specific instability in the yellow gene of the strains y ^2-217, y ^2-715, and y ^2-700 from Uman’ population of Drosophila melanogaster was studied. Crosses of the males from Uman’-derived lines with the C(1)DX,ywf/Y females yielded a cascade of derivatives, mostly consisting of y ⁺ and y ² alleles, while their crosses with the 23.5 MRF/CyL ⁴ and C(1)DX,yf; π₂ females mostly resulted in the appearance of y ⁺ and y ¹ derivatives. The genomes of laboratory strains used in the study contained the full-sized hobo elements, which could differ from one another relative to the structure of variable region and affinity to different DNA sequences.     

Inactivation of bone morphogenetic protein 1 (<Emphasis Type="Italic">Bmp1</Emphasis>) and tolloid-like 1 (<Emphasis Type="Italic">Tll1</Emphasis>) in cells expressing type I collagen leads to dental and periodontal defects in mice

Bone morphogenetic protein 1 (BMP1) and tolloid-like 1 (TLL1) belong to the BMP1/tolloid-like proteinase family, which cleaves secretory proteins. The constitutive deletion of the Bmp1 or Tll1 genes causes perinatal or embryonic lethality in mice. In this study, we first studied the β-galactosidase activity in mice in which an IRES-lacZ-Neo cassette was inserted in the intron of either the Bmp1 or the Tll1 gene; the β-galactosidase activities were used to reflect the expression of endogenous Bmp1 and Tll1, respectively. Our X-gal staining results showed that the odontoblasts in the tooth and cells in the periodontal ligament express both Bmp1 and Tll1. We then created Bmp1 ^flox/flox and Tll1 ^flox/flox mice by removing the IRES-lacZ-Neo cassette. By breeding 2.3 kb Col1a1-Cre mice with the Bmp1 ^flox/flox and Tll1 ^flox/flox mice, we further generated Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice in which both Bmp1 and Tll1 were inactivated in the Type I collagen-expressing cells. We employed X-ray radiography, histology and immunohistochemistry approaches to characterize the Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice. Our results showed that the molars of the Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice had wider predentin, thinner dentin and larger pulp chambers than those of the normal controls. The dentinal tubules of the molars in the Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice appeared disorganized. The level of dentin sialophosphoprotein in the molars of the 6-week-old Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice was lower than in the normal controls. The periodontal ligaments of the Col1a1-Cre;Bmp1 ^flox/flox ;Tll1 ^flox/flox mice were disorganized and had less fibrillin-1. Our findings indicate that the proteinases encoded by Bmp1 and Tll1 genes play essential roles in the development and maintenance of mouse dentin and periodontal ligaments.     

Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results–guided transfusion in patients with severe trauma: a randomized feasibility trial

Background:

Hemorrhage coupled with coagulopathy remains the leading cause of preventable in-hospital deaths among trauma patients. Use of a transfusion protocol with a predefined ratio of 1:1:1 (1 each of red blood cells [RBC], frozen plasma [FP] and platelets) has been associated with improved survival in retrospective studies in military and civilian settings, but such a protocol has its challenges and may increase the risk of respiratory complications. We conducted a randomized controlled trial to assess the feasibility of a 1:1:1 transfusion protocol and its effect on mortality and complications among patients with severe trauma.

Methods:

We included 78 patients seen in a tertiary trauma centre between July 2009 and October 2011 who had hypotension and bleeding and were expected to need massive transfusion (≥ 10 RBC units in 24 h). We randomly assigned them to either the fixed-ratio (1:1:1) transfusion protocol (n = 40) or to a laboratory-results–guided transfusion protocol (control; n = 38). The primary outcome, feasibility, was assessed in terms of blood product ratios and plasma wastage. Safety was measured based on 28-day mortality and survival free of acute respiratory distress syndrome.

Results:

Overall, a transfusion ratio of 1:1:1 was achieved in 57% (21/37) of patients in the fixed-ratio group, as compared with 6% (2/32) in the control group. A ratio of 1:1 (RBC:FP) was achieved in 73% (27/37) in the fixed-ratio group and 22% (7/32) in the control group. Plasma wastage was higher with the intervention protocol (22% [86/390] of FP units v. 10% [30/289] in the control group). The 28-day mortality and number of days free of acute respiratory distress syndrome were statistically similar between the groups.

Interpretation:

The fixed-ratio transfusion protocol was feasible in our study, but it was associated with increased plasma wastage. Larger randomized trials are needed to evaluate the efficacy of such a protocol in trauma care. Trial registration: ClinicalTrials.gov, no. {"type":"clinical-trial","attrs":{"text":"NCT00945542","term_id":"NCT00945542"}}NCT00945542A fixed-ratio (1:1:1) transfusion strategy is a resuscitation strategy for trauma patients that promotes the transfusion of red blood cells (RBC), plasma and platelets (PLT) at a 1:1:1 ratio while minimizing crystalloid infusion.¹ This balanced transfusion strategy aims to correct both the early coagulopathy of trauma and the volume status of patients in hemorrhagic shock, thus targeting preventable hemorrhage-related deaths.^2,3 Retrospective studies of the 1:1:1 transfusion protocol reported marked reductions in mortality based on retrospectively calculated ratios of plasma:PLT:RBC.^4–6 Methodologic limitations, particularly survivorship bias (where higher mortality was associated with low ratios of plasma and PLT to RBC in unsalvageable patients who died before 1:1:1 transfusion could be achieved), preclude any definitive conclusion on the potential benefit of a 1:1:1 transfusion strategy in terms of efficacy and safety.^7–10The 1:1:1 transfusion strategy has been widely adopted by trauma centres worldwide^11,12 and is being increasingly used in prehospital care and in the care of patients without traumatic injuries.^13–15 Widespread adoption of the strategy has significant resource and safety implications. Its full implementation requires access to thawed type AB plasma, which is chronically in short supply.¹⁶ In addition, because of the difficulty in predicting the need for massive transfusion (commonly defined as ≥ 10 RBC units in 24 h), the 1:1:1 transfusion protocol may lead to unnecessary exposure to blood components and an increased risk of acute respiratory distress syndrome, sepsis and multiple organ dysfunction.¹⁷We conducted a pilot randomized controlled trial comparing a 1:1:1 transfusion strategy with the standard of care at our institution (laboratory-results–guided transfusion; laboratory results are available for transfusion decisions throughout resuscitation) in trauma patients predicted to need massive transfusion. Our primary objective was to assess the feasibility and safety of the fixed-ratio protocol in patients with severe trauma.     

Synthesis and crystal structure of a salicylatooxovanadium(V) complex of an aminebis(phenolate) ligand: Kinetic studies on its formation from corresponding alkoxo complexes

Synthesis and single crystal X-ray structures of H₂L¹ and VO(L¹)(HL) [H₂L¹ = N,N-bis(2-hydroxy-3,5-ditertiarybutyl)-N′,N′-dimethylethylendiamine) or simply aminebis(phenol) and H₂L = salicylic acid) are reported here. The complex [VO(L¹)(HL)] is in distorted octahedral geometry under O₄N₂ donor environment where the basal core is defined by O(1), O(3), O(2) and N(5) atoms and two axial coordinates are occupied by O(4), an alkoxo-group and N(1), an imino-nitrogen atom. The electron spray mass spectrometric study on [VO(L¹)(HL)] in MeCN clearly points out the existence of single species in solution. Again, the ⁵¹V NMR of the bulk polycrystalline sample reveals that the complex [VO(L¹)(HL)] mainly exists in three out of four possible isomers. The formation of [VO(L¹)(HL)] from both [VO(L¹)(OMe)] and [VO(L¹)(OEt)] was followed kinetically by reacting with salicylic acid in MeCN. The presence of isosbestic point indicates a clean conversion of the reactants to product.     

Toxin Gene Contents and Activity of <Emphasis Type="Italic">Bacillus thuringiensis</Emphasis> Strains Against Two Sugarcane Borer Species, <Emphasis Type="Italic">Diatraea saccharalis</Emphasis> (F.) and <Emphasis Type="Italic">D. flavipennella</Emphasis> (Box)

Bacillus thuringiensis (Berliner) bears essential characteristics in the control of insect pests, such as its unique mode of action, which confers specificity and selectivity. This study assessed cry gene contents from Bt strains and their entomotoxicity against Diatraea saccharalis (F.) and Diatraea flavipennella (Box) (Lepidoptera: Crambidae). Bioassays with Bt strains were performed against neonates to evaluate their lethal and sublethal activities and were further analyzed by PCR, using primers to identify toxin genes. For D. saccharalis and D. flavipennella, 16 and 18 strains showed over 30% larval mortality in the 7th day, respectively. The LC₅₀ values of strains for D. saccharalis varied from 0.08 × 10⁵ (LIIT-0105) to 4104 × 10⁵ (LIIT-2707) spores + crystals mL^?1. For D. flavipennella, the LC₅₀ values of strains varied from 0.40 × 10⁵ (LIIT-2707) to 542 × 10⁵ (LIIT-2109) spores + crystals mL^?1. For the LIIT-0105 strain, which was the most toxic to D. saccharalis, the genes cry1Aa, cry1Ab, cry1Ac, cry1B, cry1C, cry1D, cry1F, cry1I, cry2Aa, cry2Ab, cry8, and cry9C were detected, whereas for the strain LIIT-2707, which was the most toxic to D. flavipennella, detected genes were cry1Aa, cry1Ab, cry1Ac, cry1B, cry1D, cry1F, cry1I, cry2Aa, cry2Ab, and cry9. The toxicity data and toxin gene content in these strains of Bt suggest a great variability of activity with potential to be used in the development of novel biopesticides or as source of resistance genes that can be expressed in plants to control pests.     

Tuning the formation of copper(I) coordination architectures with quinoxaline-based N,S-donor ligands by varying terminal groups of ligands and reaction temperature

Five new complexes [Cu₂(L¹)I₂]_∞ (1), [Cu(L²)I]₂ (2), {[Cu₂(L²)I₂](CH₃CN)₃}_∞ (3), [Cu₂(L³)I₂]_∞ (4) and {[Cu(L³)I](CH₃CN)}₂ (5) have been obtained by reacting three structurally related ligands, 2,3-bis(n-propylthiomethyl)quinoxaline (L¹), 2,3-bis(tert-butylthiomethyl)quinoxaline (L²) and 2,3-bis[(o-aminophenyl)thiomethyl]quinoxaline (L³) with CuI, respectively, at different temperatures. Single crystal X-ray analyses show that 1, 3, 4 possess 1D chain structures, while 2 and 5 are discrete dinuclear molecules. It is interesting that the reactions of CuI with L¹ at room temperature and 0 °C, respectively, only afforded same structure of 1 (1a and 1b), while using L² (or L³) instead, two different frameworks 2 and 3 (or 4 and 5) have been obtained. The structural changes mainly resulted from the different conformations that L² or L³ adopted at different temperatures. Our research indicates that terminal groups of ligands take an essential role in the framework formation, and the reaction temperature also has important effect on the construction of such Cu(I) coordination architectures. Furthermore, the influence of hydrogen bonds on the conformation of ligands and the supramolecular structures of these complexes have also been explored. The luminescence properties of complexes 1, 2, and 4 have been studied in solid state at room temperature.     

Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome

In this paper we report on the synthesis and characterization of three cobalt complexes described as [Co^II(L¹)₂] (1), [Co^II(L²)] (2), and [Co^III(L¹)₂]ClO₄(3). These complexes contain the deprotonated forms of the [NN′O] tridentate ligand HL¹ and its newly synthesized [N₂N′₂O₂] hexadentate counterpart H₂L², namely, 2,4-diiodo-6-((pyridine-2-ylmethylamino)methyl)phenol and 6,6′-((ethane-1,2-diylbis((pyridin-2-ylmethyl) azanediyl))bis(methylene))bis(2,4-diiodophenol). Characterizations for 1-3 include electrospray ionization (ESI) spectrometry, infrared, and UV-visible spectroscopies, and elemental analyses. A detailed ¹H-NMR study was conducted for 3 and X-ray structural data was obtained for 2. The viability of this series as potential agents for proteasome inhibition and cell apoptotic induction involving PC-3 cancer cells is presented comparing the behavior of the untethered [NN′O]₂ six-coordinate 1 and 3 and the tethered counterpart 2 with a 1:1 metal-to-ligand ratio. It is observed that the tethering in 2 decreases inhibition activity. When 1 and 3 are compared, the most inert, but redox-active, cobalt(III) species shows the highest chymotrypsin-like activity inhibition on purified proteasome and PC-3 cancer cells. A hypothesis based on the role of oxidation states for proteasome inhibition is offered.     

Synthesis, characterization and structural diversity of lanthanide chlorides supported by the β-diketiminate ligand [{(2,6-Me2C6H3)NC(Me)}2CH]

Reactions of the β-diketiminate lithium salt L²Li [L²={(2,6-Me₂C₆H₃)NC(Me)}₂CH] with anhydrous LnCl₃ (Ln=Yb, Sm, Nd) in 1:1 molar ratio in THF afforded the new β-diketiminate lanthanide complexes L²LnCl(THF)(μ-Cl)₂Li(THF)₂ (Ln=Yb (1), Sm (2), Nd (3)). Recrystallization of complexes 1-3 from toluene gave the neutral complexes L²LnCl₂(THF)₂ (Ln=Yb (4), Sm (5), Nd (6)). Recrystallization of complexes 4 and 5 in hot toluene for two times gave the dinuclear complexes L²ClLn(μ-Cl)₃LnL²(THF) (Ln=Yb (7), Sm (8)). Treatment of the mother liquor of complex 2 in hot toluene for three times gave the novel trinuclear complex L²SmCl(μ-Cl)₃SmL²(μ-Cl)Li(L²H)(THF) (9). Each of these complexes was well characterized, while complexes 3, 7 and 9 have been characterized by X-ray diffraction structure determination.